Supply Chain

Consumers forced to buy a new pack of EpiPens every year can blame epinephrine directly. The drug is notoriously unstable, limiting an EpiPen's shelf life to just 18 months, reported The Washington Post.

The third time is not the charm for Austin, Texas-based Pain Therapeutics. The Food and Drug Administration rejected the company's abuse-deterrent opioid painkiller Remoxy for the third time Monday, reports The Street.

The Food and Drug Administration recently approved Johnson & Johnson's best-selling drug Stelara to treat adults with Crohn's disease, reported Reuters.

SUNNYVALE, Calif., and WILMINGTON, N.C. — Viewics, a healthcare-focused insights company that provides hospitals and health systems with laboratory-driven solutions for advanced analytics, today announced that it has signed an agreement to make its solutions available to members of the…

The American Red Cross is still low on blood donations after a serious shortage this summer, said Christy McPeters, a spokeswoman for the Red Cross.

The Food and Drug Administration recently approved Ahead 300, a handheld medical device that helps clinicians diagnose a traumatic brain injury.

When Mylan CEO Heather Bresch testified before the House Oversight Committee Sept. 21, she told lawmakers the company makes $100 in profit off a two-pack of EpiPens listed at $608. However, Ms. Bresch failed to indicate this number was estimated…

After VanMoof realized its high-end bikes kept getting damaged when shipped to customers, the Amsterdam-based bicycle manufacturer came up with a simple fix: print an image of a flat screen TV on the side of their boxes.

The Food and Drug Administration approved expanded treatment uses for the anti-inflammatory drug llaris, developed by Basel, Switzerland-based Novartis.

Pfizer said it will not split into two publicly traded companies — one for brand name drugs and one for generics — after finding the move would not benefit shareholders, reported Reuters.